Search Results - "Luo, Jiyu"

Conventional Frailty Index Does Not Predict Risk of Postoperative Complications in Patients With IBD: A Multicenter Cohort Study by Rozich, Jacob J., Zhao, Beiqun, Luo, Jiyu, Luo, William Y., Eisenstein, Samuel, Singh, Siddharth

“…Frailty has been associated with adverse outcomes in patients with IBD. This study aimed to evaluate the association between health deficit-defined frailty…”
Get full text

Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016 by Singh, Siddharth, Qian, Alexander S, Nguyen, Nghia H, Ho, Stephanie K M, Luo, Jiyu, Jairath, Vipul, Sandborn, William J, Ma, Christopher

“…Abstract Background Inflammatory bowel diseases (IBD) are rising in prevalence and are associated with high health care costs. We estimated trends in U.S…”
Get full text

Efficient Massive MIMO Detection for M-QAM Symbols by Quan, Zhi, Luo, Jiyu, Zhang, Hailong, Jiang, Li

“…Massive multiple-input multiple-output (MIMO) systems significantly outperform small-scale MIMO systems in terms of data rate, making them an enabling…”
Get full text

Simulation-Enhanced MQAM Modulation Identification in Communication Systems: A Subtractive Clustering-Based PSO-FCM Algorithm Study by Quan, Zhi, Zhang, Hailong, Luo, Jiyu, Sun, Haijun

“…Signal modulation recognition is often reliant on clustering algorithms. The fuzzy c-means (FCM) algorithm, which is commonly used for such tasks, often…”
Get full text

Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study by Gu, Phillip, Luo, Jiyu, Kim, Jihoon, Paul, Paulina, Limketkai, Berkeley, Sauk, Jenny S., Park, Sunhee, Parekh, Nimisha, Zheng, Kai, Rudrapatna, Vivek, Syal, Gaurav, Ha, Christina, McGovern, Dermot P., Melmed, Gil Y., Fleshner, Phillip, Eisenstein, Samuel, Ramamoorthy, Sonia, Dulai, Parambir S., Boland, Brigid S., Grunvald, Eduardo, Mahadevan, Uma, Ohno-Machado, Lucila, Sandborn, William J., Singh, Siddharth

“…INTRODUCTION: Obesity is variably associated with treatment response in biologic-treated patients with inflammatory bowel diseases (IBD). We evaluated the…”
Get full text

Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD by Heerspink, Hiddo J L, Inker, Lesley A, Tighiouart, Hocine, Collier, Willem H, Haaland, Benjamin, Luo, Jiyu, Appel, Gerald B, Chan, Tak Mao, Estacio, Raymond O, Fervenza, Fernando, Floege, Jürgen, Imai, Enyu, Jafar, Tazeen H, Lewis, Julia B, Kam-Tao Li, Philip, Locatelli, Francesco, Maes, Bart D, Perna, Annalisa, Perrone, Ronald D, Praga, Manuel, Schena, Francesco P, Wanner, Christoph, Xie, Di, Greene, Tom

“…Changes in albuminuria and GFR slope are individually used as surrogate end points in clinical trials of CKD progression, and studies have demonstrated that…”
Get full text

Impact of recurrent hospitalization for Clostridioides difficile on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort by Venkat, Preethi G., Nguyen, Nghia H., Luo, Jiyu, Qian, Alexander S., Khanna, Sahil, Singh, Siddharth

“…Background: Clostridioides difficile infection (CDI) is associated with poor outcomes in patients with inflammatory bowel diseases (IBD). Objectives: We…”
Get full text

S697 Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease with Active or Recent Malignancy: A Multi-Center Cohort Study by Holmer, Ariela K., Luo, Jiyu, Park, Sarah, Yang, Jeong Yun, Nguyen, Vu Q., Sofia, M. Anthony, Ertem, Furkan, Dueker, Jeffrey M., Petrov, Jessica C., Al Bawardy, Badr F., Llano, Ernesto M., Fudman, David, Joseph, Dailey, Jangi, Sushrut, Russ, Kirk, Khakoo, Nidah S., Damas, Oriana, Barnes, Edward L., Hong, Simon J., Zenger, Cameron, Axelrad, Jordan, Scott, Frank I., MSCE, Ungaro, Ryan, Singh, Siddharth

Get full text

Distributed adaptive Huber regression by Luo, Jiyu, Sun, Qiang, Zhou, Wen-Xin

“…Distributed data naturally arise in scenarios involving multiple sources of observations, each stored at a different location. Directly pooling all the data…”
Get full text

Statistical Robustness - Distributed Linear Regression, Informative Censoring, Causal Inference, and Non-Proportional Hazards by Luo, Jiyu

“…Robustness broadly refers to the property of the statistical method being valid even when some of the model assumptions are violated. We investigate 4 types of…”
Get full text

IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN’S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY by Ahuja, Dhruv, Luo, Jiyu, Qi, Yuchen, Syal, Gaurav, Boland, Brigid, Chang, John, Ma, Christopher, Jairath, Vipul, Xu, Ronghui, Singh, Siddharth

Get full text

Conventional Frailty Index Does Not Predict Risk of Postoperative Complications in Patients with Inflammatory Bowel Diseases: A Multi-Center Cohort Study by Rozich, Jacob J., Zhao, Beiqun, Luo, Jiyu, Luo, William Y., Eisenstein, Samuel, Singh, Siddharth

Get full text

Mo1476: IMPACT OF RECURRENT HOSPITALIZATION FOR CLOSTRIDIOIDES DIFFICILE ON LONGITUDINAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES by Venkat, Preethi, Nguyen, Nghia H., Luo, Jiyu, Qian, Alexander, Singh, Siddharth

Get full text

IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN’S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY by Ahuja, Dhruv, Luo, Jiyu, Qi, Yuchen, Syal, Gaurav, Boland, Brigid, Chang, John, Ma, Christopher, Jairath, Vipul, Xu, Ronghui, Singh, Siddharth

“…Abstract BACKGROUND AND AIMS Treatment efficacy and safety are primary factors in choosing therapies in patients with Crohn’s disease (CD). However, they can…”
Get full text

Associations between prenatal exposure to per- and polyfluoroalkyl substances and plasma immune molecules in three-year-old children in China by Huang, Haiyun, Li, Xiaojun, Deng, Yican, San, Siyi, Qiu, Dongmei, Xu, Ao, Luo, Jiyu, Xu, Lingyun, Li, Yang, Zhang, Hongling, Li, Yuanyuan

“…Many studies have reported that prenatal exposure to Per- and Polyfluoroalkyl Substances (PFASs) can disrupt immune function. However, little is known about…”
Get full text

Siesta: Synthesizing Proxy Applications for MPI Programs by Luo, Jiyu, Yan, Tao, Xu, Qingguo, Sun, Jingwei, Sun, Guangzhong

“…Proxy applications (proxy-apps) are basic tools for evaluating the performance of specific workloads on high-performance computing (HPC) systems. Since the…”
Get full text

Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID Registry by Ahuja, Dhruv, Luo, Jiyu, Qi, Yuchen, Syal, Gaurav, Boland, Brigid S, Chang, John, Ma, Christopher, Jairath, Vipul, Xu, Ronghui, Singh, Siddharth

“…Traditional risk factors for serious infections with advanced therapies in patients with Crohn's disease (CD) have been assessed at baseline before starting…”
Get full text

Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases by Meserve, Joseph, Luo, Jiyu, Zhu, Wenhong, Veeravalli, Nina, Bandoli, Gretchen, Chambers, Christina D., Singh, Abha G., Boland, Brigid S., Sandborn, William J., Mahadevan, Uma, Singh, Siddharth

“…We conducted a retrospective cohort study to inform the safety of exposure to immunosuppressive and/or biologic agents around conception in expectant fathers…”
Get full text

Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort by Nguyen, Nghia H, Luo, Jiyu, Ohno-Machado, Lucila, Sandborn, William J, Singh, Siddharth

“…Abstract Background Fragmentation of care (FoC) may adversely impact health care quality in patients with chronic diseases. We conducted a US nationally…”
Get full text

Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study by Singh, Siddharth, Kim, Jihoon, Luo, Jiyu, Paul, Paulina, Rudrapatna, Vivek, Park, Sunhee, Zheng, Kai, Syal, Gaurav, Ha, Christina, Fleshner, Phillip, McGovern, Dermot, Sauk, Jenny S., Limketkai, Berkeley, Dulai, Parambir S., Boland, Brigid S., Eisenstein, Samuel, Ramamoorthy, Sonia, Melmed, Gil, Mahadevan, Uma, Sandborn, William J., Ohno-Machado, Lucila

“…We compared the safety and effectiveness of tumor necrosis factor α (TNF-α) antagonists vs vedolizumab vs ustekinumab in patients with Crohn’s disease (CD) in…”
Get full text